Remove topic gene-therapy
article thumbnail

Unleashing the power of computational tools in rare disease

Clarivate

In the vast landscape of pharmaceutical innovation, few therapy areas present challenges and opportunities as compelling as those faced in rare disease. One of the topics discussed was how companies can ensure data quality, accuracy, and completeness when dealing with rare diseases.

article thumbnail

Pharma R&D productivity dips, but efficiency gains give hope

Clarivate

R&D productivity fell in 2022, but late-phase cancellations are also trending down The rise and fall of R&D productivity across the global biopharmaceutical industry is a well-documented and much discussed topic, with industry commentators quantifying productivity in many ways (e.g., Learn more about purchasing it here.

2013 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New findings on 171 hot and emerging Research Fronts

Clarivate

As in previous reports, the latest compendium of fast-moving Research Fronts reflects a broad range of specialty areas and topics. In chemistry, for example, “chromodynamic therapy” involves the harnessing of a chemical reaction in the human body to kill cancer cells while causing little harm to normal tissue. A broad range.

2021 98
article thumbnail

The future of scRNA-Seq applicability

Clarivate

In recent years, the field of drug discovery and development has undergone a remarkable transformation thanks to the advent of single-cell technologies, particularly single-cell RNA sequencing (scRNA-seq) – the profiling of gene expression at the level of individual cells – and its accompanying computational tools.

Webinar 52